Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    6504041 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Leucovorin for the Treatment of 5 q Minus Syndrome
Conditions: 5q Minus Syndrome;   Myelodysplastic Syndrome
Intervention: Drug: Leucovorin

Indicates status has not been verified in more than two years